Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
McKinsey
UBS
Express Scripts
Citi
Accenture
Mallinckrodt
US Army

Generated: April 26, 2018

DrugPatentWatch Database Preview

LEVO-DROMORAN Drug Profile

« Back to Dashboard

When do Levo-dromoran patents expire, and when can generic versions of Levo-dromoran launch?

Levo-dromoran is a drug marketed by Valeant Pharm Intl and is included in two NDAs.

The generic ingredient in LEVO-DROMORAN is levorphanol tartrate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levorphanol tartrate profile page.
Drug patent expirations by year for LEVO-DROMORAN
Medical Subject Heading (MeSH) Categories for LEVO-DROMORAN
Synonyms for LEVO-DROMORAN
( -)-N-Methylmorphinan-3-ol
(-) 3-hydroxy-N-methylmorphinan
(-)-3-Hydroxy-N-methylmorphinan
(-)-N-Methylmorphinan-3-ol
(+-)-17-Methylmorphinan-3-ol
(+-)-3-Hydroxy-N-methylmorphinan
(+)-3-Hydroxy-17-methylmorphinan
(+)-cis-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol
(+)-N-Methylmorphinan-3-ol
(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.0;{1,10}.0;{2,7}]heptadeca-2(7),3,5-trien-4-ol
(1R,9R,10R)-17-METHYL-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2,4,6-TRIEN-4-OL
(1R,9R,10R)-17-METHYL-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2(7),3,5-TRIEN-4-OL
1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, dl-mixture
1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, l-
125-74-6
17-Methylmorphinan-3-ol
17-Methylmorphinan-3-ol, (+)- #
27618J1N2X
297-90-5
2H-10, 4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, dl-
2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-
2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, l-
3-Hydroxy-N-methylmorphinan
77-07-6
9.alpha.,13.alpha.,14.alpha.-Morphinan-3-ol, 17-methyl-
Antalgin
Aromarone
BDBM224028
BDBM50017233
BDBM50369518
BDBM82427
C08014
C17H23NO
CAS_5985-38-6
Cetarin
CHEBI:6444
CHEMBL592
d-Form of levorphanol
D00FWI
D08123
D0T3HY
DB00854
DEA No. 9220
DEA No. 9733
Dextro-Dromoran
dl-3-Hydroxy-N-methylmorphinan
Dromoran
DTXSID3023213
EINECS 201-002-6
EINECS 206-048-0
GTPL7595
HSDB 3349
JAQUASYNZVUNQP-USXIJHARSA-N
L-Dromoran
Levodroman
Levorfanol
Levorfanol [INN-Spanish]
Levorfanolo
Levorfanolo [DCIT]
Levorphan
Levorphanal
levorphanol
Levorphanol (INN)
Levorphanol [INN:BAN]
Levorphanol dl-form
LEVORPHANOL HYDROCHLORIDE
LEVORPHANOL-tartarate
Levorphanolum
Levorphanolum [INN-Latin]
LS-91821
LS-92022
Methorfinan
Methorfinan [Czech]
Methorphinan
Morphinan-3-ol, 17-methyl-
Morphinan-3-ol, 17-methyl-, (-)-
Morphinan-3-ol, 17-methyl-, (+-)-
Morphinan-3-ol, 17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-
Morphinan, 3-hydroxy-17-methyl-
Morphinan, 3-hydroxy-N-methyl-, (+-)-
N-Methyl-3-hydroxymorphinan
NU 2206
OR060534
Orphan
PL000501
PL053425
PL069476
Racemethorphanum
Racemic dromoran
Racemorfano
Racemorfano [INN-Spanish]
Racemorphan
Racemorphan [INN:BAN]
Racemorphane
Racemorphane [INN-French]
Racemorphanum
Racemorphanum [INN-Latin]
Ro 1-5431
SCHEMBL24335
UNII-27618J1N2X
UNII-V7R79HN3XD component JAQUASYNZVUNQP-USXIJHARSA-N
ZINC3812984

US Patents and Regulatory Information for LEVO-DROMORAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl LEVO-DROMORAN levorphanol tartrate INJECTABLE;INJECTION 008719-001 Dec 19, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl LEVO-DROMORAN levorphanol tartrate TABLET;ORAL 008720-001 Dec 19, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Citi
McKesson
US Department of Justice
Deloitte
McKinsey
Colorcon
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.